Publications
Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone
14 April 2013
Journal of Allergy and Clinical Immunology
Gene Colice, Richard J. Martin, Elliot Israel, Nicolas Roche, Neil Barnes, Anne Burden, Peter Polos, Paul Dorinsky, Elizabeth V. Hillyer, Amanda J. Lee, Alison Chisholm, Julie von Ziegenweidt,Francesca Barion, David Price
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort
12 February 2013
The Lancet Respiratory Medicine
Rupert C M Jones, David Price, Dermot Ryan, Erika J Sims, Julie von Ziegenweidt, Laurence Mascarenhas, Anne Burden, David M G Halpin, Robert Winter, Sue Hill, Matt Kearney, Kevin Holton, Anne Moger, Daryl Freeman, Alison Chisholm, Eric D Bateman, on behalf of The Respiratory Effectiveness Group
Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial
22 September 2012
PharmacoEconomics
Edward C.F. Wilson, Erika J. Sims, Stanley D. Musgrave, Lee Shepstone, Annie Blyth, Jamie Murdoch, H. Miranda Mugford, Elizabeth F. Juniper, Jon G. Ayres, Stephanie Wolfe, Daryl Freeman, Richard F.T. Gilbert, Ian Harvey, Elizabeth V. Hillyer, David Price
Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care
5 April 2012
Allergy, Asthma & Immunology Research
David Price, Henry Chrystyn, Alan Kaplan, John Haughney, Miguel Román-Rodríguez, Annie Burden, Alison Chisholm, Elizabeth V. Hillyer, Julie von Ziegenweidt, Muzammil Ali
A survey on the management of acute rhinosinusitis among Asian physicians
31 July 2011
Rhinology
De-Yun Wang, Retno S. Wardani, Kuljit Singh, Sanguansak Thanaviratananich, Gil Vicente, Geng Xu, Mohammad Rashid Zia, Achal Gulati, Sheen-Yie Fang, Li Shi, Yiong-Huak Chan, David Price, Valerie J. Lund, Joaquim Mullol, Wytske J. Fokkens
Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study
13 July 2011
Clinical and Experimental Allergy
Barnes, David Price, G. Colice, A. Chisholm, P. Dorinsky, E. V. Hillyer, A. Burden, A. J. Lee, R. J. Martin, N. Roche, J. von Ziegenweidt, E. Israel
Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial
13 July 2011
Pharmacoeconomics
Edward C.F. Wilson, David Price, Stanley D. Musgrave, Erika J. Sims, Lee Shepstone, Jamie Murdoch, H. Miranda Mugford, Annie Blyth, Elizabeth F. Juniper, Jon G. Ayres, Stephanie Wolfe, Daryl Freeman, Richard F.T. Gilbert, Elizabeth V. Hillyer, Ian Harvey
Leukotriene antagonists as first-line or add-on asthma-controller therapy
4 May 2011
The New England Journal of Medicine
David Price, Stanley D. Musgrave, Lee Shepstone, Elizabeth V. Hillyer, Erika J. Sims, Richard F.T. Gilbert, Elizabeth F. Juniper, Jon G. Ayres, Linda Kemp, Annie Blyth, Edward C.F. Wilson, Stephanie Wolfe, Daryl Freeman, H. Miranda Mugford, Jamie Murdoch, Ian Harvey
Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study
8 August 2010
Journal of Allergy and Clinical Immunology
David Price, Richard J. Martin, Neil Barnes, Paul Dorinsky, Elliot Israel, Nicolas Roche, Alison Chisholm, Elizabeth V. Hillyer, Linda Kemp, Amanda J. Lee, Julie von Ziegenweidt, Gene Colice
Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study
30 June 2010
ClinicoEconomics and Outcomes Research
Linda Kemp, John Haughney, Neil Barnes, Erika Sims, Julie von Ziegenweidt, Elizabeth V Hillyer, Amanda J Lee, Alison Chisholm, David Price